pathway_name,pathway_source,num_overlapping_metabolites,overlapping_metabolites,num_all_pathway_metabolites,P_metabolites,Q_metabolites
Metabolism of water-soluble vitamins and cofactors,Reactome,5,C00378;C03150;C00051;C05552;C01134,98 (122),0.000146,0.624
Metabolism of water-soluble vitamins and cofactors,Wikipathways,4,C00378;C00051;C01134;C05552,67 (79),0.000405,0.866
Metabolism of vitamins and cofactors,Reactome,5,C00378;C03150;C00051;C05552;C01134,136 (180),0.000675,0.96
glutathione biosynthesis,HumanCyc,2,C00669;C00051,9 (9),0.000991,1
Sulfation Biotransformation Reaction,Wikipathways,2,C00051;C00059,10 (10),0.00123,1
Glutathione synthesis and recycling,Reactome,2,C00669;C00051,14 (14),0.00246,1
Folate biosynthesis - Homo sapiens (human),KEGG,3,C04874;C05926;C21008,57 (57),0.00338,1
Glutathione metabolism,Wikipathways,2,C00669;C00051,19 (19),0.00455,1
Sepiapterin reductase deficiency,SMPDB,2,C05926;C04874,20 (20),0.00504,1
Segawa syndrome,SMPDB,2,C05926;C04874,20 (20),0.00504,1
Pterine Biosynthesis,SMPDB,2,C05926;C04874,20 (20),0.00504,1
Dopa-responsive dystonia,SMPDB,2,C05926;C04874,20 (20),0.00504,1
Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency,SMPDB,2,C05926;C04874,20 (20),0.00504,1
Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps),SMPDB,2,C05926;C04874,20 (20),0.00504,1
Hyperphenylalaninemia due to dhpr-deficiency,SMPDB,2,C05926;C04874,20 (20),0.00504,1
Benzo(a)pyrene metabolism,Wikipathways,1,C07535,1 (5),0.00542,1
stress induction of hsp regulation,BioCarta,1,C00051,1 (1),0.00542,1
Overview of nanoparticle effects,Wikipathways,1,C00051,1 (2),0.00542,1
Gamma-glutamyl-transpeptidase deficiency,SMPDB,2,C00669;C00051,22 (22),0.00609,1
5-oxoprolinase deficiency,SMPDB,2,C00669;C00051,22 (22),0.00609,1
Gamma-Glutamyltransferase Deficiency,SMPDB,2,C00669;C00051,22 (22),0.00609,1
Glutathione Metabolism,SMPDB,2,C00669;C00051,22 (22),0.00609,1
Glutathione Synthetase Deficiency,SMPDB,2,C00669;C00051,22 (22),0.00609,1
5-Oxoprolinuria,SMPDB,2,C00669;C00051,22 (22),0.00609,1
Ferroptosis,Wikipathways,2,C00669;C00051,24 (29),0.00723,1
Glutathione conjugation,Reactome,2,C00669;C00051,28 (31),0.00977,1
Biotin metabolism - Homo sapiens (human),KEGG,2,C20387;C05552,28 (28),0.00977,1
&gamma;-glutamyl cycle,HumanCyc,2,C00669;C00051,29 (29),0.0105,1
multi-drug resistance factors,BioCarta,1,C00051,2 (2),0.0108,1
Influenza A virus infection,Wikipathways,1,C00051,2 (2),0.0108,1
Thiamine metabolism - Homo sapiens (human),KEGG,2,C00378;C02892,31 (31),0.0119,1
Ferroptosis - Homo sapiens (human),KEGG,2,C00669;C00051,31 (31),0.0119,1
Glutamate Glutamine metabolism,INOH,2,C00669;C00051,34 (34),0.0142,1
Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation,Wikipathways,1,C00051,3 (3),0.0162,1
Acrylamide Biotransformation and Exposure Biomarkers,Wikipathways,1,C00051,3 (4),0.0162,1
Glutathione metabolism - Homo sapiens (human),KEGG,2,C00669;C00051,38 (38),0.0176,1
Vitamin digestion and absorption - Homo sapiens (human),KEGG,2,C00378;C05552,39 (39),0.0185,1
One carbon metabolism and related pathways,Wikipathways,2,C00669;C00051,42 (42),0.0213,1
Biosynthesis of maresin conjugates in tissue regeneration (MCTR),Reactome,1,C00051,4 (8),0.0215,1
Sodium-coupled sulphate_ di- and tri-carboxylate transporters,Reactome,1,C00059,4 (4),0.0215,1
NAD metabolism_ sirtuins and aging,Wikipathways,1,C03150,4 (4),0.0215,1
Phase II - Conjugation of compounds,Wikipathways,3,C00051;C00669;C00059,119 (151),0.0254,1
Phase II - Conjugation of compounds,Reactome,3,C00051;C00669;C00059,120 (148),0.026,1
thiamin salvage III,HumanCyc,1,C00378,5 (5),0.0268,1
sulfite oxidation,HumanCyc,1,C00059,5 (5),0.0268,1
glutathione redox reactions II,HumanCyc,1,C00051,5 (5),0.0268,1
Ascorbate and aldarate metabolism - Homo sapiens (human),KEGG,2,C14899;C05385,48 (48),0.0273,1
2-Hydroxyglutric Aciduria (D And L Form),SMPDB,2,C00669;C00051,48 (49),0.0273,1
Homocarnosinosis,SMPDB,2,C00669;C00051,48 (49),0.0273,1
Hyperinsulinism-Hyperammonemia Syndrome,SMPDB,2,C00669;C00051,48 (49),0.0273,1
Succinic semialdehyde dehydrogenase deficiency,SMPDB,2,C00669;C00051,48 (49),0.0273,1
4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,SMPDB,2,C00669;C00051,48 (49),0.0273,1
Glutamate Metabolism,SMPDB,2,C00669;C00051,48 (49),0.0273,1
Urea cycle and metabolism of arginine_ proline_ glutamate_ aspartate and asparagine,EHMN,3,C00669;C00051;C05932,125 (125),0.0289,1
ABC transporters - Homo sapiens (human),KEGG,3,C00378;C00051;C00059,129 (129),0.0313,1
CS/DS degradation,Reactome,1,C00059,6 (16),0.0321,1
Digestion resistant carbohydrate metabolism,Wikipathways,1,C00059,6 (6),0.0321,1
Transport of bile salts and organic acids_ metal ions and amine compounds,Wikipathways,2,C00059;C05570,53 (77),0.0328,1
Sulfur amino acid metabolism,Wikipathways,2,C00059;C00051,53 (67),0.0328,1
Pentose and glucuronate interconversions - Homo sapiens (human),KEGG,2,C14899;C05385,55 (55),0.0351,1
Transport and synthesis of PAPS,Reactome,1,C00059,7 (7),0.0374,1
Biosynthesis of aspirin-triggered D-series resolvins,Reactome,1,C00051,7 (19),0.0374,1
Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR),Reactome,1,C00051,7 (17),0.0374,1
Biosynthesis of DHA-derived sulfido conjugates,Reactome,1,C00051,7 (21),0.0374,1
sulfate activation for sulfonation,HumanCyc,1,C00059,7 (7),0.0374,1
Biotin Metabolism,SMPDB,1,C05552,7 (7),0.0374,1
Multiple carboxylase deficiency_ neonatal or early onset form,SMPDB,1,C05552,7 (7),0.0374,1
Biotinidase Deficiency,SMPDB,1,C05552,7 (7),0.0374,1
Cysteine and methionine metabolism - Homo sapiens (human),KEGG,2,C00051;C00059,61 (61),0.0424,1
4-hydroxy-2-nonenal detoxification,HumanCyc,1,C00051,8 (8),0.0426,1
Glycerophospholipid catabolism,Reactome,1,C00670,8 (11),0.0426,1
Hydrolysis of LPC,Reactome,1,C00670,8 (9),0.0426,1
Glycine Metabolism,Wikipathways,1,C00051,8 (10),0.0426,1
Biological oxidations,Reactome,4,C00051;C00669;C00059;C03150,249 (321),0.0427,1
Androgen and estrogen biosynthesis and metabolism,EHMN,2,C00059;C00051,62 (62),0.0437,1
Acetylcholine Synthesis,Wikipathways,1,C00670,9 (9),0.0478,1
Biotin transport and metabolism,Reactome,1,C05552,9 (9),0.0478,1
Keratan sulfate degradation,Reactome,1,C00059,9 (9),0.0478,1
Vitamin B1 (thiamin) metabolism,Reactome,1,C00378,9 (9),0.0478,1
methylglyoxal degradation I,HumanCyc,1,C00051,9 (11),0.0478,1
Multifunctional anion exchangers,Reactome,1,C00059,9 (10),0.0478,1
Pyruvaldehyde Degradation,SMPDB,1,C00051,9 (9),0.0478,1
Thiamine Metabolism,SMPDB,1,C00378,9 (9),0.0478,1
Arginine Proline metabolism,INOH,2,C00669;C05932,68 (68),0.0516,1
Vitamin C (ascorbate) metabolism,Reactome,1,C00051,10 (12),0.053,1
Biosynthesis of E-series 18(R)-resolvins,Reactome,1,C00051,10 (14),0.053,1
ascorbate recycling (cytosolic),HumanCyc,1,C00051,10 (10),0.053,1
Putative anti-Inflammatory metabolites formation from EPA,EHMN,1,C00051,10 (10),0.053,1
Metabolism,Reactome,9,C00669;C05552;C00378;C01134;C00670;C03150;C00059;C17935;C00051,951 (1384),0.054,1
Transport of bile salts and organic acids_ metal ions and amine compounds,Reactome,2,C00059;C05570,70 (78),0.0544,1
Methionine metabolism and related disorders,Wikipathways,1,C00059,11 (13),0.0581,1
Biosynthesis of E-series 18(S)-resolvins,Reactome,1,C00051,11 (19),0.0581,1
Biosynthesis of D-series resolvins,Reactome,1,C00051,11 (23),0.0581,1
Choline metabolism in cancer - Homo sapiens (human),KEGG,1,C00670,11 (11),0.0581,1
Sulfur relay system - Homo sapiens (human),KEGG,1,C00378,11 (11),0.0581,1
formaldehyde oxidation,HumanCyc,1,C00051,11 (11),0.0581,1
superoxide radicals degradation,HumanCyc,1,C00051,11 (11),0.0581,1
Vitamin B1 (thiamin) metabolism,EHMN,1,C00378,11 (11),0.0581,1
Vitamin H (biotin) metabolism,EHMN,1,C05552,11 (11),0.0581,1
HS-GAG degradation,Reactome,1,C00059,12 (23),0.0632,1
Synthesis of 12-eicosatetraenoic acid derivatives,Reactome,1,C00051,12 (12),0.0632,1
NAD+ biosynthetic pathways,Wikipathways,1,C03150,12 (13),0.0632,1
Coenzyme A biosynthesis,Reactome,1,C01134,13 (13),0.0683,1
Synthesis of 5-eicosatetraenoic acids,Reactome,1,C00051,13 (15),0.0683,1
coenzyme A biosynthesis,HumanCyc,1,C01134,13 (13),0.0683,1
Acetaminophen Metabolism Pathway,SMPDB,1,C00051,13 (16),0.0683,1
glutathione-mediated detoxification,HumanCyc,1,C00051,14 (14),0.0734,1
Sulfide oxidation to sulfate,Reactome,1,C00059,14 (15),0.0734,1
Regulation of pyruvate dehydrogenase (PDH) complex,Reactome,1,C00051,14 (14),0.0734,1
Organic anion transporters,Reactome,1,C00059,14 (15),0.0734,1
Aflatoxin activation and detoxification,Reactome,1,C00051,14 (25),0.0734,1
Trans-sulfuration pathway,Wikipathways,1,C00051,14 (14),0.0734,1
ROS_ RNS production in phagocytes,Wikipathways,1,C00051,14 (19),0.0734,1
NAD+ metabolism,Wikipathways,1,C03150,14 (14),0.0734,1
Biosynthesis of EPA-derived SPMs,Wikipathways,1,C00051,15 (27),0.0784,1
Chondroitin sulfate/dermatan sulfate metabolism,Reactome,1,C00059,15 (25),0.0784,1
Synthesis of 15-eicosatetraenoic acid derivatives,Reactome,1,C00051,15 (16),0.0784,1
Bile salt and organic anion SLC transporters,Reactome,1,C00059,15 (17),0.0784,1
Biosynthesis of EPA-derived SPMs,Reactome,1,C00051,15 (27),0.0784,1
Melanin biosynthesis,Wikipathways,1,C17935,15 (23),0.0784,1
Biosynthesis of DHA-derived SPMs,Wikipathways,1,C00051,16 (72),0.0834,1
Aflatoxin activation and detoxification,Wikipathways,1,C00051,16 (29),0.0834,1
Tolerance by Mtb to nitric oxide produced by macrophages,Reactome,1,C00051,16 (22),0.0834,1
ROS_ RNS production in phagocytes,Reactome,1,C00051,17 (21),0.0884,1
Melanin biosynthesis,Reactome,1,C17935,17 (23),0.0884,1
Vitamin B5 (pantothenate) metabolism,Reactome,1,C01134,17 (17),0.0884,1
Xenobiotics metabolism,EHMN,2,C07535;C00051,93 (93),0.0894,1
Biochemical Pathways Part I,Wikipathways,5,C00051;C05385;C00059;C01134;C00669,456 (467),0.0934,1
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,Reactome,1,C00051,18 (18),0.0934,1
Keratan sulfate/keratin metabolism,Reactome,1,C00059,18 (18),0.0934,1
Biosynthesis of DHA-derived SPMs,Reactome,1,C00051,18 (72),0.0934,1
Glycerophospholipid metabolism,EHMN,2,C00670;C04874,96 (96),0.0944,1
Chemical carcinogenesis - Homo sapiens (human),KEGG,2,C19488;C07535,99 (99),0.0994,1
Detoxification of Reactive Oxygen Species,Reactome,1,C00051,21 (24),0.108,1
Synthesis of Leukotrienes (LT) and Eoxins (EX),Reactome,1,C00051,21 (28),0.108,1
Thyroid hormone synthesis - Homo sapiens (human),KEGG,1,C00051,21 (21),0.108,1
Pantothenate and CoA Biosynthesis,SMPDB,1,C01134,21 (21),0.108,1
Vitamin B5 - CoA biosynthesis from pantothenate,EHMN,1,C01134,21 (21),0.108,1
TP53 Regulates Metabolic Genes,Wikipathways,1,C00051,21 (25),0.108,1
Tyrosine metabolism,EHMN,2,C00051;C00059,105 (105),0.11,1
Amino Acid metabolism,Wikipathways,2,C00669;C00051,105 (108),0.11,1
Sulfate/Sulfite Metabolism,SMPDB,1,C00059,22 (22),0.113,1
Sulfite oxidase deficiency,SMPDB,1,C00059,22 (22),0.113,1
Amino sugar and nucleotide sugar metabolism - Homo sapiens (human),KEGG,2,C04037;C05385,108 (108),0.115,1
arsenate detoxification I (glutaredoxin),HumanCyc,1,C00051,23 (24),0.118,1
Arginine biosynthesis - Homo sapiens (human),KEGG,1,C04133,23 (23),0.118,1
TP53 Regulates Metabolic Genes,Reactome,1,C00051,23 (25),0.118,1
Cyclophosphamide Action Pathway,SMPDB,1,C00051,23 (23),0.118,1
Cyclophosphamide Metabolism Pathway,SMPDB,1,C00051,23 (23),0.118,1
Detoxification of Reactive Oxygen Species,Wikipathways,1,C00051,23 (26),0.118,1
Heparan sulfate/heparin (HS-GAG) metabolism,Reactome,1,C00059,24 (35),0.123,1
PI Metabolism,Wikipathways,1,C00670,24 (29),0.123,1
Linoleate metabolism,EHMN,1,C00051,24 (24),0.123,1
Biopterin metabolism,EHMN,1,C04874,24 (24),0.123,1
Pyruvate metabolism,Reactome,1,C00051,25 (25),0.127,1
Ether lipid metabolism - Homo sapiens (human),KEGG,1,C00670,25 (25),0.127,1
PI Metabolism,Reactome,1,C00670,25 (29),0.127,1
Prostaglandin Leukotriene metabolism,INOH,1,C00051,25 (25),0.127,1
Organic cation transport,Reactome,1,C05570,26 (29),0.132,1
Nicotinate Nicotinamide metabolism,INOH,1,C03150,26 (26),0.132,1
Beta-mercaptolactate-cysteine disulfiduria,SMPDB,1,C00669,26 (26),0.132,1
Cysteine Metabolism,SMPDB,1,C00669,26 (26),0.132,1
Cystinosis_ ocular nonnephropathic,SMPDB,1,C00669,26 (26),0.132,1
Latent infection of Homo sapiens with Mycobacterium tuberculosis,Wikipathways,1,C00051,26 (35),0.132,1
Response of Mtb to phagocytosis,Reactome,1,C00051,26 (35),0.132,1
Latent infection of Homo sapiens with Mycobacterium tuberculosis,Reactome,1,C00051,26 (35),0.132,1
Trans-sulfuration pathway,Wikipathways,1,C00051,27 (28),0.137,1
Leukotriene metabolism,EHMN,1,C00051,27 (27),0.137,1
Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human),KEGG,2,C19488;C07535,121 (121),0.139,1
Pantothenate and CoA biosynthesis - Homo sapiens (human),KEGG,1,C01134,28 (28),0.142,1
Metabolism of amino acids and derivatives,Reactome,3,C00051;C00059;C17935,246 (285),0.146,1
Metabolic reprogramming in colon cancer,Wikipathways,1,C00051,29 (35),0.146,1
Biosynthesis of specialized proresolving mediators (SPMs),Reactome,1,C00051,29 (140),0.146,1
leukotriene biosynthesis,HumanCyc,1,C00051,29 (30),0.146,1
Dopamine metabolism,Wikipathways,1,C00051,29 (32),0.146,1
Pyruvate metabolism,INOH,1,C00051,31 (31),0.156,1
Phenylalanine and tyrosine catabolism,Reactome,1,C00051,31 (31),0.156,1
Vitamin A Deficiency,SMPDB,1,C00670,31 (31),0.156,1
Retinol Metabolism,SMPDB,1,C00670,31 (31),0.156,1
Trans-sulfuration and one carbon metabolism,Wikipathways,1,C00051,31 (33),0.156,1
17-Beta Hydroxysteroid Dehydrogenase III Deficiency,SMPDB,1,C00059,32 (32),0.16,1
Androgen and Estrogen Metabolism,SMPDB,1,C00059,32 (32),0.16,1
Aromatase deficiency,SMPDB,1,C00059,32 (32),0.16,1
Metabolism of lipids,Reactome,4,C00051;C00059;C00670;C01134,398 (620),0.164,1
Methylation,Reactome,1,C00051,33 (37),0.165,1
Sulfur metabolism - Homo sapiens (human),KEGG,1,C00059,33 (33),0.165,1
Organic cation/anion/zwitterion transport,Reactome,1,C05570,33 (36),0.165,1
Degradation of cysteine and homocysteine,Reactome,1,C00059,34 (39),0.169,1
Transport of inorganic cations-anions and amino acids-oligopeptides,Wikipathways,1,C00059,34 (58),0.169,1
Pentose phosphate pathway - Homo sapiens (human),KEGG,1,C01218,35 (35),0.174,1
Transcriptional Regulation by TP53,Reactome,1,C00051,35 (37),0.174,1
Nicotinate and Nicotinamide Metabolism,SMPDB,1,C03150,35 (35),0.174,1
superpathway of methionine degradation,HumanCyc,1,C00059,36 (36),0.178,1
Vitamin B3 (nicotinate and nicotinamide) metabolism,EHMN,1,C03150,36 (36),0.178,1
Glycosaminoglycan metabolism,Wikipathways,1,C00059,36 (58),0.178,1
Cytosolic sulfonation of small molecules,Reactome,1,C00059,37 (47),0.183,1
Pentose phosphate pathway,EHMN,1,C01218,37 (37),0.183,1
Synthesis of Prostaglandins (PG) and Thromboxanes (TX),Reactome,1,C00051,38 (43),0.187,1
Glycosphingolipid metabolism,Reactome,1,C00059,38 (41),0.187,1
Nicotinate metabolism,Wikipathways,1,C03150,38 (55),0.187,1
Peroxisomal lipid metabolism,Reactome,1,C01134,39 (60),0.192,1
Sphingolipid Metabolism,SMPDB,1,C00059,39 (40),0.192,1
Gaucher Disease,SMPDB,1,C00059,39 (40),0.192,1
Globoid Cell Leukodystrophy,SMPDB,1,C00059,39 (40),0.192,1
Metachromatic Leukodystrophy (MLD),SMPDB,1,C00059,39 (40),0.192,1
Fabry disease,SMPDB,1,C00059,39 (40),0.192,1
Krabbe disease,SMPDB,1,C00059,39 (40),0.192,1
Glycosaminoglycan metabolism,Reactome,1,C00059,40 (60),0.196,1
Peroxisomal lipid metabolism,Wikipathways,1,C01134,40 (61),0.196,1
Purine catabolism,Reactome,1,C00051,41 (53),0.201,1
SLC-mediated transmembrane transport,Reactome,2,C00059;C05570,155 (166),0.204,1
Cellular responses to stress,Reactome,1,C00051,42 (48),0.205,1
Nicotinate metabolism,Reactome,1,C03150,42 (52),0.205,1
The citric acid (TCA) cycle and respiratory electron transport,Wikipathways,1,C00051,43 (44),0.209,1
Pyruvate metabolism and Citric Acid (TCA) cycle,Reactome,1,C00051,44 (44),0.214,1
Infectious disease,Reactome,1,C00051,44 (55),0.214,1
Amino acid and oligopeptide SLC transporters,Reactome,1,C00059,44 (50),0.214,1
Interconversion of nucleotide di- and triphosphates,Wikipathways,1,C00051,44 (51),0.214,1
Generic Transcription Pathway,Reactome,1,C00051,45 (49),0.218,1
Histidine metabolism,EHMN,1,C00051,45 (45),0.218,1
Pyruvate Dehydrogenase Complex Deficiency,SMPDB,1,C00051,46 (46),0.222,1
Pyruvate kinase deficiency,SMPDB,1,C00051,46 (46),0.222,1
Leigh Syndrome,SMPDB,1,C00051,46 (46),0.222,1
Pyruvate Metabolism,SMPDB,1,C00051,46 (46),0.222,1
Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),SMPDB,1,C00051,46 (46),0.222,1
Primary hyperoxaluria II_ PH2,SMPDB,1,C00051,46 (46),0.222,1
Histidine metabolism - Homo sapiens (human),KEGG,1,C05570,47 (47),0.227,1
Interconversion of nucleotide di- and triphosphates,Reactome,1,C00051,47 (52),0.227,1
Prostaglandin formation from arachidonate,EHMN,1,C00051,48 (48),0.231,1
RNA Polymerase II Transcription,Reactome,1,C00051,48 (52),0.231,1
Cellular responses to external stimuli,Reactome,1,C00051,50 (57),0.239,1
Transport of inorganic cations/anions and amino acids/oligopeptides,Reactome,1,C00059,50 (56),0.239,1
Glycerophospholipid metabolism - Homo sapiens (human),KEGG,1,C00670,52 (52),0.247,1
Arachidonic acid metabolism,EHMN,1,C00051,53 (53),0.252,1
Selenoamino acid metabolism,Wikipathways,1,C00051,53 (59),0.252,1
The citric acid (TCA) cycle and respiratory electron transport,Reactome,1,C00051,54 (56),0.256,1
Sulfur amino acid metabolism,Reactome,1,C00059,54 (66),0.256,1
Nicotinate and nicotinamide metabolism - Homo sapiens (human),KEGG,1,C03150,55 (55),0.26,1
Selenoamino acid metabolism,Reactome,1,C00051,56 (61),0.264,1
Gene expression (Transcription),Reactome,1,C00051,57 (66),0.268,1
Sphingolipid metabolism,Wikipathways,1,C00059,59 (67),0.276,1
C21-steroid hormone biosynthesis and metabolism,EHMN,1,C00059,61 (61),0.284,1
Sphingolipid metabolism,Reactome,1,C00059,62 (68),0.288,1
Fatty acid metabolism,Reactome,2,C00051;C01134,199 (367),0.294,1
glutathione redox reactions I,HumanCyc,1,C00051,64 (100),0.296,1
Transport of small molecules,Reactome,2,C00059;C05570,203 (226),0.302,1
Innate Immune System,Reactome,1,C00051,67 (99),0.307,1
Glycerophospholipid biosynthesis,Wikipathways,1,C00670,70 (94),0.319,1
Histidine_ lysine_ phenylalanine_ tyrosine_ proline and tryptophan catabolism,Wikipathways,1,C00051,70 (91),0.319,1
Leukotriene C4 Synthesis Deficiency,SMPDB,1,C00051,71 (71),0.322,1
Antrafenine Action Pathway,SMPDB,1,C00051,71 (71),0.322,1
Trisalicylate-choline Action Pathway,SMPDB,1,C00051,71 (71),0.322,1
Lornoxicam Action Pathway,SMPDB,1,C00051,71 (71),0.322,1
Tenoxicam Action Pathway,SMPDB,1,C00051,71 (71),0.322,1
Arachidonic Acid Metabolism,SMPDB,1,C00051,71 (71),0.322,1
Naproxen Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Magnesium salicylate Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Disease,Reactome,1,C00051,72 (104),0.326,1
Valdecoxib Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Glycerophospholipid biosynthesis,Reactome,1,C00670,72 (93),0.326,1
Etodolac Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Ketoprofen Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Rofecoxib Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Acetylsalicylic Acid Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Diflunisal Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Acetaminophen  Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Sulindac Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Diclofenac Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Ketorolac Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Etoricoxib Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Carprofen Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Flurbiprofen Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Fenoprofen Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Antipyrine Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Lumiracoxib Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Nepafenac Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Phenylbutazone Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Salsalate Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Tiaprofenic Acid Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Tolmetin Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Salicylic Acid Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Salicylate-sodium Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Oxaprozin Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Nabumetone Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Indomethacin Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Meloxicam Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Suprofen Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Bromfenac Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Mefenamic Acid Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Piroxicam Action Pathway,SMPDB,1,C00051,72 (72),0.326,1
Celecoxib Action Pathway,SMPDB,1,C00051,75 (76),0.337,1
Ibuprofen Action Pathway,SMPDB,1,C00051,77 (77),0.344,1
Tyrosine metabolism - Homo sapiens (human),KEGG,1,C17935,78 (78),0.348,1
Arginine and proline metabolism - Homo sapiens (human),KEGG,1,C05932,78 (78),0.348,1
Tryptophan metabolism,EHMN,1,C00051,78 (78),0.348,1
Phospholipid metabolism,Reactome,1,C00670,80 (103),0.355,1
Methionine and cysteine metabolism,EHMN,1,C00059,80 (80),0.355,1
Purine nucleotides nucleosides metabolism,INOH,1,C00059,80 (80),0.355,1
Tryptophan metabolism - Homo sapiens (human),KEGG,1,C05641,81 (81),0.359,1
Nucleobase catabolism,Wikipathways,1,C00051,82 (100),0.362,1
Arachidonic acid metabolism,Reactome,1,C00051,84 (104),0.369,1
Selenium Micronutrient Network,Wikipathways,1,C00051,84 (103),0.369,1
Arachidonic acid metabolism,Wikipathways,1,C00051,84 (107),0.369,1
Histidine_ lysine_ phenylalanine_ tyrosine_ proline and tryptophan catabolism,Reactome,1,C00051,85 (91),0.373,1
Nucleobase catabolism,Reactome,1,C00051,86 (100),0.376,1
Glycine_ serine_ alanine and threonine metabolism,EHMN,1,C00051,88 (88),0.383,1
Immune System,Reactome,1,C00051,91 (136),0.393,1
Purine metabolism,EHMN,1,C00059,94 (94),0.403,1
Purine metabolism - Homo sapiens (human),KEGG,1,C00059,95 (95),0.407,1
chondroitin sulfate degradation (metazoa),HumanCyc,1,C00059,100 (134),0.423,1
dermatan sulfate degradation (metazoa),HumanCyc,1,C00059,101 (135),0.426,1
Metabolism of carbohydrates,Reactome,1,C00059,111 (137),0.457,1
Metabolism of nucleotides,Reactome,1,C00051,132 (152),0.517,1
Phase I - Functionalization of compounds,Wikipathways,1,C03150,157 (195),0.581,1
Phase I - Functionalization of compounds,Reactome,1,C03150,159 (193),0.585,1
Bile secretion - Homo sapiens (human),KEGG,1,C00051,162 (162),0.592,1